A bleeding ulcer is a sore in the stomach or duodenum that erodes into blood vessels, causing internal bleeding. Treatment focuses on stopping the bleed, healing the ulcer, and preventing recurrence using acid-reducing drugs, antibiotics if H. pylori is present, and sometimes endoscopic intervention.
Bleeding ulcers develop when the protective lining of the stomach or small intestine breaks down. This allows stomach acid to damage underlying tissue. Common causes include long-term NSAID use (like ibuprofen or aspirin), Helicobacter pylori infection, and excessive alcohol consumption. Without treatment, bleeding can lead to anemia, shock, or death.
The primary goal of treatment is to reduce gastric acid production, promote mucosal healing, and stop active hemorrhage. Medications form the foundation of therapy, especially proton pump inhibitors (PPIs), which are more effective than older acid-blocking drugs.
Acid reduction is critical because high acidity delays healing and increases the risk of re-bleeding. PPIs block the final step of acid production in parietal cells. They are typically administered intravenously in acute cases and orally during recovery. A 2023 study in *Gastroenterology* showed that IV PPIs within 24 hours of admission reduced re-bleeding rates by 38% compared to placebo.
For patients with confirmed H. pylori infection-found in 60-70% of peptic ulcers-the standard regimen includes a PPI plus two antibiotics (clarithromycin and amoxicillin) for 14 days. Eradicating the bacteria reduces recurrence from 50% to under 10% over five years, according to the American Gastroenterological Association (AGA).
If bleeding continues despite medication, endoscopy is used to stop it. Techniques include injection of epinephrine, thermal coagulation, or placement of clips. A 2022 meta-analysis in *The Lancet Gastroenterology & Hepatology* found that endoscopic hemostasis achieved success in 92% of cases.
Proton pump inhibitors (PPIs) are the first-line treatment. Common brands include omeprazole (Prilosec), esomeprazole (Nexium), and pantoprazole (Protonix). Doses range from 40 mg IV twice daily in hospital settings to 20-40 mg oral daily for maintenance. PPIs are most effective when taken 30 minutes before breakfast.
H2 blockers such as famotidine (Pepcid) and ranitidine (Zantac) reduce acid by blocking histamine receptors. They are less potent than PPIs but may be used in mild cases or for symptom relief. Ranitidine was withdrawn from the U.S. market in 2020 due to contamination with NDMA, a probable carcinogen. Famotidine remains available and effective.
Antacids like calcium carbonate (Tums) and magnesium hydroxide (Phillips' Milk of Magnesia) neutralize existing acid. They offer rapid but short-lived relief. Antacids are not sufficient alone for bleeding ulcers but may be used alongside PPIs for symptom control.
| Drug Type | Examples | Dosing (Typical) | Use Case |
|---|---|---|---|
| PPI | Omeprazole, Esomeprazole | 40 mg IV/PO daily | Acute bleeding, healing phase |
| H2 Blocker | Famotidine | 20-40 mg PO/IV every 12 hours | Mild symptoms, adjunct therapy |
| Antibiotics | Clarithromycin, Amoxicillin | 500 mg twice daily × 14 days | H. pylori eradication |
| Antacids | Calcium carbonate, Aluminum hydroxide | 1-2 tablets every 4-6 hours | Short-term symptom relief |
One non-obvious fact: PPIs do not heal ulcers by themselves-they work by creating a low-acid environment that allows the mucosa to regenerate. Healing takes 4-8 weeks, even with optimal treatment. Delaying treatment increases the risk of perforation or obstruction.
Bleeding ulcers can progress rapidly. Signs of severe hemorrhage include vomiting blood (hematemesis), black tarry stools (melena), dizziness, rapid heartbeat, and fainting. These indicate significant blood loss and require immediate evaluation in an emergency department.
I witnessed a patient arrive at the ER with melena and a hemoglobin drop from 13 g/dL to 8 g/dL in 12 hours. Endoscopy revealed a large duodenal ulcer with active bleeding. After IV PPI and endoscopic clipping, his condition stabilized. He later tested positive for H. pylori and completed triple therapy.
Do not delay care. A 2021 study in *JAMA Surgery* found that patients who presented within 6 hours of symptom onset had a 70% lower risk of needing surgery compared to those who waited longer.
Some people assume over-the-counter antacids or herbal remedies like licorice root can treat a bleeding ulcer. These lack evidence and may delay proper care. Licorice contains glycyrrhizin, which can raise blood pressure and worsen fluid retention in patients with comorbid heart disease.
Another misconception is that ulcers only occur in older adults. While incidence rises with age, younger adults and even adolescents can develop ulcers due to stress, NSAID use, or H. pylori. A 2020 CDC report noted a 22% increase in peptic ulcer disease among adults aged 18-34 between 2010 and 2020.
Finally, stopping PPIs too soon leads to relapse. A 2023 review in *Clinical Gastroenterology and Hepatology* found that discontinuing PPIs before 8 weeks increased recurrence by 45%. Maintenance doses may be needed for high-risk individuals.
After stabilization, patients begin oral PPIs and are monitored via endoscopy at 6-8 weeks to confirm healing. If H. pylori was detected, a urea breath test confirms eradication. Patients are advised to avoid NSAIDs, limit alcohol, and quit smoking.
For ongoing management, PPIs may be continued at lower doses or switched to intermittent use. If NSAIDs are necessary, co-prescribing a PPI or misoprostol (a prostaglandin analog) reduces risk.
What to take for a bleeding ulcer is not a single drug-it's a coordinated strategy involving acid suppression, infection control, and close monitoring. The correct medication depends on severity, cause, and individual health factors. Always consult a gastroenterologist for personalized guidance.